Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Deutsche Bank Securities, Inc., Medical Equipment Deals Advised By Year, 2004 to YTD 2009 6
Deutsche Bank Securities, Inc., Medical Equipment Deals Advised By Type, 2004 to YTD 2009 7
Deutsche Bank Securities, Inc., Medical Equipment Deals Advised By Region, 2004 to YTD 2009 8
Deutsche Bank Securities, Inc., Medical Equipment Deals Advised By Market, 2004 to YTD 2009 9
Deutsche Bank Securities, Inc., Medical Equipment Deals Advised Summary, 2004 to YTD 2009 10
Deutsche Bank Securities, Inc., Medical Equipment, Deal Details 14
Acquisition 14
Medco Health Solutions Acquires PolyMedica 14
Fresenius Medical Care Acquires Renal Care Group 15
Equity Offerings 17
ThermoGenesis Completes Public Offering Of $35.2 Million 17
Stereotaxis Completes Public Offering Of $66 Million 18
Home Diagnostics Completes Initial Public Offering Of $39.6 Million 19
Restore Medical Completes Initial Public Offering Of $32 Million 21
Biomimetic Therapeutics Completes Initial Public Offering of $36.8 Million 22
BioMimetic Therapeutics Completes Public Offering Of $50.44 Million 23
Alphatec Holdings Completes Initial Public Offering Of $83.7 Million 25
Stereotaxis Completes Initial Public Offering Of $47.7 Million 26
MAP Pharmaceuticals Completes Initial Public Offering Of $69 Million 27
Kinetic Concepts Completes Initial Public Offering Of $105 Million 28
AutoGenomics Files For Initial Public Offering Of $86.3 Million 29
AGA Medical Holdings Files For Initial Public Offering Of $178.5 Million 30
Stereotaxis Completes Private Placement Of $20 Million 32
Masimo Completes Initial Public Offering Of $55.89 Million 34
AMAG Pharmaceuticals Completes Public Offering Of $162.85 Million 36
HealthPort Files For Initial Public Offering Of $100 Million 38
MAP Pharmaceuticals Announces Pricing Of Registered Public Offering Of Shares For $33.95 Million 39
MedAssets Completes Initial Public Offering Of $244.72 Million 40
Debt Offerings 41
Baxter International Completes Public Offering Of 6.25% Senior Notes For $500 Million 41
Dupont Completes 5% Notes Offering For $750 Million 42
Abbott Laboratories Completes Public Offering Of Notes Due 2012 For $1,000 Million 43
Abbott Laboratories Completes Public Offering Of Notes Due 2017 For $1,500 Million 45
Abbott Laboratories Completes Public Offering Of Notes Due 2037 For $1,000 Million 47
Lincare Holdings Completes Private Placement Of Series A Debentures For $275 Million 49
Lincare Holdings Completes Private Placement Of Series B Debentures For $275 Million 50
Covidien Completes Private Placement Of 5.15% Senior Notes For $250 Million 51
Covidien Completes Private Placement Of 5.45% Senior Notes For $500 Million 52
Covidien Completes Private Placement Of 6% Senior Note For $1,150 Million 53
Covidien Completes Private Placement Of 6.55% Senior Notes For $850 Million 54
Medtronic Completes Public Offering Of 4.5% Senior Notes For $550 Million 55
Medtronic Completes Public Offering Of 5.6% Senior Notes For $400 Million 56
Medtronic Completes Public Offering Of 6.5% Senior Notes For $300 Million 57
Eli Lilly Completes Public Offering Of 3.55% Notes For $1,000 Million 58
Eli Lilly Completes Public Offering Of 4.2% Notes For $1,000 Million 59
Eli Lilly Completes Public Offering Of 5.95% Notes For $400 Million 60
Danaher Completes Public Offering Of 5.4% Senior Notes For $750 Million 61
Abbott Laboratories Completes Public Offering Of 5.125% Notes For $2,000 Million 62
Abbott Laboratories Completes Public Offering Of 6% Notes For $1,000 Million 64
Baxter International Completes Public Offering Of 4% Senior Notes For $350 Million 65
DuPont Issues $398.86 Million 4.75% Notes Due 2015 66
DuPont Issues $498.23 Million 5.75% Notes Due 2019 67
Eli Lilly Completes Public Offering Of 5.2% Notes For $1,000 Million 68
Eli Lilly Completes Public Offering Of 5.5% Notes For $696 Million 69
Eli Lilly Completes Public Offering Of 5.55% Notes For $795 Million 70
Illumina Completes Private Placement Of $400 Million 71
Cardinal Health Completes Private Placement Of 5.65% Senior Notes For $300 Million 72
Cardinal Health Completes Private Placement Of 6% Senior Notes For $300 Million 73
Dupont Completes 5% Notes Offering For $750 Million 74
Dupont Completes 6% Notes Offering For $1.25 Billion 76
Johnson & Johnson Completes Public Offering Of Notes Due 2018 For $900 Million 77
Johnson & Johnson Completes Public Offering Of Notes Due 2038 For $700 Million 78
Baxter International Completes Public Offering Of 5.375% Senior Notes For $500 Million 79
Johnson & Johnson Completes Public Offering Of 5.15% Notes Due 2012 For $600 Million 80
Johnson & Johnson Completes Public Offering Of 5.55% Notes Due 2017 For $1,000 Million 81
Johnson & Johnson Completes Public Offering Of 5.95% Notes Due 2037 For $1,000 Million 83
Eli Lilly Completes Public Offering Of Floating Rate Notes Due 2007 For $1,000 Million 84
Boston Scientific Completes $600 Million Of 5.45% Senior Notes Offering 85
AstraZeneca Completes Public Offering Of 5.4% Notes Due 2014 For $750 million 86
deCODE genetics Completes Private Placement Of Senior Notes For $150 Million 87
Abbott Laboratories Completes Public Offering Of 5.375% Notes For $500 Million 88
Abbott Laboratories Completes Public Offering Of Notes Due 2011 For $1,500 Million 90
Abbott Laboratories Completes Public Offering Of Notes Due 2016 For $2,000 Million 92
Dupont Completes 5.25% Notes Offering For $600 Million 94
DuPont Completes 5.6% Notes Offering For $400 Million 95
Cardinal Health Completes Private Placement Of 5.8% Senior Notes For $500 Million 96
Cardinal Health Completes Private Placement Of Floating Rate Senior Notes For $350 Million 97
Baxter International Completes Public Offering Of 5.9% Senior Notes For $600 Million 98
Boston Scientific Completes Public Offering Of 6% Senior Notes For $600 Million 99
Boston Scientific Completes Pubic Offering Of 5.5% Senior Notes For $400 Million 100
Boston Scientific Completes Public Offering Of 6.25% Senior Notes For $350 Million 101
Sanmina-SCI Completes Private Placement Of $600 Million 102
Appendix 103
Methodology 103
About Global Markets Direct 103
Contact Us 103
Disclaimer 103